Employers encourage weight loss medications like GLP-1 receptor agonists through direct-to-consumer platforms and health savings accounts for employees.
Managing chronic conditions can be overwhelming, chronic care management is key to connected care experience for millions of Americans living with chronic…
Discover how Neffy generated $72.2 million in sales within its first year, securing insurance coverage from major providers like United Healthcare.
Updated trial data shows the ALK inhibitor lorlatinib achieves record progression-free survival for lung cancer, potentially changing treatment guidelines.